Coralie Reger de Moura

Author

Also Known As

C. Reger de Moura, Coralie Reger De Moura, Coralie Reger de Moura

Publications

311

Citations

H-Index

Concepts

All Affiliations

Coralie Reger de Moura is an author at Inserm specializing in tumor biology, tumor microenvironment, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	13
2	Cell Biology	1	1	13
3	Immunology	1	1	13
4	Immunotherapy	1	1	13
5	Tumor Biology	1	1	13

Coralie Reger de Moura

Publications

119

Citations

H-Index

Page 1

	Year	Citations
Discoidin domain receptors: A promising target in melanoma Coralie Reger de Moura, Maxime Battistella, Anjum Sohail, Pigment Cell & Melanoma Research	2019	33
Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in <i>BRAF</i> V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism Baptiste Louveau, Matthieu Resche‐Rigon, Thierry Lesimple, Clinical Cancer Research	2021	18
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors Baptiste Louveau, Julie Delyon, Coralie Reger de Moura, Oncotarget	2019	17
Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma Coralie Reger de Moura, Laëtitia Vercellino, Fanélie Jouenne, Translational Oncology	2019	15
CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1 Coralie Reger de Moura, Alexandra Landras, Farah Khayati, Cancers Cancer ImmunosurveillanceAngiogenesisEndothelial CellsMedicineMelanoma	2021	13
Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care Baptiste Louveau, Fanélie Jouenne, Coralie Reger de Moura, Cancers	2019	12
TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro Julie Delyon, A. Vallet, Mélanie Bernard-Cacciarella, Cancers	2023	11

Page 1